About Biocartesian
Biocartesian is a company based in Philadelphia (United States) founded in 2022.. Biocartesian has raised $500 thousand across 1 funding round from investors including Y Combinator. Biocartesian offers products and services including Tissue Profiling, Data Visualization and Analysis, Cell Culture Services, and Screening Services.
- Headquarter Philadelphia, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$500 K (USD)
in 1 rounds
-
Latest Funding Round
$500 K (USD), Seed
Jun 01, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biocartesian
Biocartesian offers a comprehensive portfolio of products and services, including Tissue Profiling, Data Visualization and Analysis, Cell Culture Services, and Screening Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Profiles DNA, RNA, and proteins in tissue sections for research purposes.
Delivers AI-powered segmentation and automated data analysis workflows.
Provides high-throughput RNA and protein profiling for screening.
Offers co-culture models and omics for experimental applications.
Funding Insights of Biocartesian
Biocartesian has successfully raised a total of $500K through 1 strategic funding round. The most recent funding activity was a Seed round of $500 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $500,000
-
First Round
First Round
(01 Jun 2024)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2024 | Amount | Seed - Biocartesian | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biocartesian
Biocartesian has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biocartesian
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biocartesian
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biocartesian Comparisons
Competitors of Biocartesian
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Biocartesian
When was Biocartesian founded?
Biocartesian was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Where is Biocartesian located?
Biocartesian is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Is Biocartesian a funded company?
Biocartesian is a funded company, having raised a total of $500K across 1 funding round to date. The company's 1st funding round was a Seed of $500K, raised on Jun 01, 2024.
What does Biocartesian do?
Biocartesian was founded in 2022 in Philadelphia, United States, within the biotechnology sector. Tissue sections are analyzed for DNA, RNA, and proteins through integrated chemistry and microscopy techniques. Data visualization and analysis are supported by AI-powered tools and automated workflows. Additional services encompass cell culture, high-throughput profiling, screening, and co-culture model omics, aiding biological research via advanced imaging methods.
What products or services does Biocartesian offer?
Biocartesian offers Tissue Profiling, Data Visualization and Analysis, Cell Culture Services, and Screening Services.
Who are Biocartesian's investors?
Biocartesian has 1 investor. Key investors include Y Combinator.